Page 264 - Haematologica - Vol. 105 n. 6 - June 2020

Y. Lu et al.
1993;90(3):1004-1008.
30. Bertina RM, Koeleman BP, Koster T, et al.
Mutation in blood coagulation factor V asso- ciated with resistance to activated protein C. Nature. 1994;369(6475):64-67.
31. Pineda AO, Zhang E, Guinto ER, Savvides SN, Tulinsky A, Di Cera E. Crystal structure of the thrombin mutant D221A/D222K: the Asp222:Arg187 ion-pair stabilizes the fast form. Biophys Chem. 2004;112(2-3):253- 256.
32. Qureshi SH, Yang L, Manithody C, Iakhiaev AV, Rezaie AR. Mutagenesis studies toward understanding allostery in thrombin. Biochemistry. 2009;48(34):8261-8270.
33. Rezaie AR, Kittur FS. The critical role of the 185-189-loop in the factor Xa interaction with Na+ and factor Va in the prothrombi- nase complex. J Biol Chem. 2004;279(46):48262-48269.
34. Dang QD, Di Cera E. Residue 225 deter- mines the Na(+)-induced allosteric regula- tion of catalytic activity in serine proteases. Proc Natl Acad Sci U S A. 1996;93(20):10653-10656.
35. Greengard JS, Fisher CL, Villoutreix B, Griffin JH. Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: patterns revealed by three-dimen- sional molecular modelling of mutations of the protease domain. Proteins. 1994;18(4):367-380.
36. Kalafatis M, Mann KG. Role of the mem- brane in the inactivation of factor Va by acti- vated protein C. J Biol Chem. 1993;268(36):27246-27257.
37. Nicolaes GA, Tans G, Thomassen MC, et al. Peptide bond cleavages and loss of function- al activity during inactivation of factor Va and Factor VaR506Q by activated protein C.
J Biol Chem. 1995;270(36):21158-21166.
38. Rosing J, Hoekema L, Nicolaes GA, et al. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein
C. J Biol Chem. 1995;270(46):27852-27858. 39. Ohlin AK, Landes G, Bourdon P, Oppenheimer C, Wydro R, Stenflo J. Beta- hydroxyaspartic acid in the first epidermal growth factor-like domain of protein C. Its role in Ca2+ binding and biological activity.
J Biol Chem. 1988;263(35):19240-19248.
40. Boerger LM, Morris PC, Thurnau GR, Esmon CT, Comp PC. Oral contraceptives and gender affect protein S status. Blood.
1987;69(2):692-694.
41. Comp PC, Thurnau GR, Welsh J, Esmon CT.
Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986;68(4):881-885.
1722
haematologica | 2020; 105(6)